Inotrem

Inotrem

Inotrem

INOTREM SA is a biopharmaceutical company discovering and developing firstinclass immunotherapies for the treatment of inflammatory diseases.
Founded
2013
Raised
$21.7M
Follow us
Alexa global traffic share
Latest funding
$23,158,800
Venture capital (Series A) - 2014
Team Size
1–10
Employees

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Inotrem makes some noise.